https://www.selleckchem.com/pr....oducts/DMXAA(ASA404)
This work is development of new hydantoin molecules as treatment of potential antibacterial and antifungal activity against clinical pathogens causing infectious disease. Synthesized compounds were evaluated in molecular docking studies, the most effective compound is used to dock against the targets of 1U1Z, and 1AI9 kinases, to evaluate its binding affinity, hoping to rationalize and obtain potent of antibacterial, antifungal agents. The FTIR, H C NMR, and mass spectra were used to conform new molecules and their evaluatio
Like
Comment
Share
